photo aphria: Licensed producer Aphria Inc. says it has exited the U.S. market for now by completing the sale of its remaining holdings in Liberty Health Sciences Inc, according to The Toronto Star. Aphria / THE CANADIAN PRESS file photo Aphria said it will re-enter the American market and become a significant player in the U.S. cannabis industry when its federal laws are changed. The Ontario-based company said it has signed an agreement with a group of buyers to sell 64.1 million shares in Liberty Health for 59.1 million. Read more Cannabis company Aphria expands to South America, Jamaica with acquisition Article Continued Below Weed company Aphria sells part of stake in U.S. firm as it pulls from country Aphria strikes deal with wine and spirits supplier Southern Glazer's for cannabis distribution We view this decision as only a temporary departure from investment in the U.S. cannabis industry until such time as U.S. federal cannabis laws are reformed, stated CEO Vic Neufeld. It retains an irrevocable option to repurchase the shares for up to five years. react-empty 139 The shares will be held in escrow until a five-year promissory note due in 2023 is paid. We have always believed in the tremendous opportunity in the U.S. cannabis market, and that is no different today.
(news.financializer.com). As
reported in the news.
Tagged under photo aphria, american market topics.